Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision history now lists v3.5.4 as the latest revision, replacing the previous v3.5.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer’s software/version indicator is updated from Revision v3.5.2 to Revision v3.5.3, reflecting a maintenance or release update rather than a change to the trial record itself.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision history now includes v3.5.2 and removes v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study history.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision v3.4.3 was added to the study record history and Revision v3.4.2 was removed.SummaryDifference0.1%

- Check101 days agoChange DetectedAdded revision: v3.4.2 to the history and removed revision v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.